Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Leonard Rich, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
MDR-TB Treatment in Nepal and A Retrospective Study of the Nepal Eye Bank
International, 07/04/05 - 08/26/05

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood S, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binedgie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2023 Feb 21. PMID: 36802336.
    Citations:    Fields:    
  2. Zeng C, Mitnick CD, Hewison C, Bastard M, Khan P, Seung KJ, Rich ML, Atwood S, Melikyan N, Morchiladze N, Khachatryan N, Khmyz M, Restrepo CG, Salahuddin N, Kazmi E, Dahri AA, Ahmed S, Varaine F, Vilbrun SC, Oyewusi L, Gelin A, Tintaya K, Yeraliyeva LT, Hamid S, Khan U, Huerga H, Franke MF. Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):34-40. PMID: 36853128; PMCID: PMC9879081.
    Citations:    Fields:    
  3. Huerga H, Khan U, Bastard M, Mitnick CD, Lachenal N, Khan PY, Seung KJ, Melikyan N, Ahmed S, Rich ML, Varaine F, Osso E, Rashitov M, Salahuddin N, Salia G, Sánchez E, Serobyan A, Rafi Siddiqui M, Grium Tefera D, Vetushko D, Yeghiazaryan L, Holtzman D, Islam S, Kumsa A, Jacques Leblanc G, Leonovich O, Mamsa S, Manzur-Ul-Alam M, Myint Z, Padayachee S, Franke MF, Hewison C. Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs. Clin Infect Dis. 2022 10 12; 75(8):1307-1314. PMID: 35243494; PMCID: PMC9555840.
    Citations:    Fields:    
  4. Hewison C, Khan U, Bastard M, Lachenal N, Coutisson S, Osso E, Ahmed S, Khan P, Franke MF, Rich ML, Varaine F, Melikyan N, Seung KJ, Adenov M, Adnan S, Danielyan N, Islam S, Janmohamed A, Karakozian H, Kamene Kimenye M, Kirakosyan O, Kholikulov B, Krisnanda A, Kumsa A, Leblanc G, Lecca L, Nkuebe M, Mamsa S, Padayachee S, Thit P, Mitnick CD, Huerga H. Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort. Clin Infect Dis. 2022 09 29; 75(6):1006-1013. PMID: 35028659; PMCID: PMC9522425.
    Citations:    Fields:    
  5. Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95. Int J Infect Dis. 2022 Aug; 121:105. PMID: 35613479.
    Citations:    Fields:    
  6. Khan PY, Franke MF, Hewison C, Seung KJ, Huerga H, Atwood S, Ahmed S, Khan M, Sultana T, Manzur-Ul-Alam M, Vo LNQ, Lecca L, Yae K, Kozhabekov S, Tamirat M, Gelin A, Vilbrun SC, Kikvidze M, Faqirzai J, Kadyrov A, Skrahina A, Mesic A, Avagyan N, Bastard M, Rich ML, Khan U, Mitnick CD. All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings. Eur Respir J. 2022 01; 59(1). PMID: 34140298.
    Citations: 1     Fields:    Translation:Humans
  7. Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, Bonnet M, Chang E, Cloez S, Coit JM, Cox V, de Jong BC, Delifer C, Do JM, Tozzi DDS, Ducher V, Ferlazzo G, Gouillou M, Khan A, Khan U, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moschioni M, O'Brien K, Okunbor O, Oyewusi L, Panda S, Patil SB, Phillips PPJ, Pichon L, Rupasinghe P, Rich ML, Saluhuddin N, Seung KJ, Tamirat M, Trippa L, Cellamare M, Velásquez GE, Wasserman S, Zimetbaum PJ, Varaine F, Mitnick CD. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial. Trials. 2021 Sep 25; 22(1):651. PMID: 34563240.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  8. Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S91-S95. PMID: 33823277.
    Citations: 1     Fields:    Translation:Humans
  9. Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, Rich ML, Zarli K, Samieva N, Oyewusi L, Nair P, Mudassar M, Melikyan N, Lenggogeni P, Lecca L, Kumsa A, Khan M, Islam S, Hussein K, Docteur W, Chumburidze N, Berikova E, Atshemyan H, Atwood S, Alam M, Ahmed S, Bastard M, Mitnick CD. Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study. Am J Respir Crit Care Med. 2021 01 01; 203(1):111-119. PMID: 32706644; PMCID: PMC7781121.
    Citations: 9     Fields:    Translation:Humans
  10. Seung KJ, Khan U, Varaine F, Ahmed S, Bastard M, Cloez S, Damtew D, Franke MF, Herboczek K, Huerga H, Islam S, Karakozian H, Khachatryan N, Kliesckova J, Khan AJ, Khan M, Khan P, Kotrikadze T, Lachenal N, Lecca L, Lenggogeni P, Maretbayeva S, Melikyan N, Mesic A, Mitnick CD, Mofolo M, Perrin C, Richard M, Tassew YM, Telnov A, Vilbrun SC, Wanjala S, Rich ML, Hewison C. Introducing new and repurposed TB drugs: the endTB experience. Int J Tuberc Lung Dis. 2020 10 01; 24(10):1081-1086. PMID: 33126943.
    Citations:    Fields:    Translation:Humans
  11. Thomson DR, Amoroso C, Atwood S, Bonds MH, Rwabukwisi FC, Drobac P, Finnegan KE, Farmer DB, Farmer PE, Habinshuti A, Hirschhorn LR, Manzi A, Niyigena P, Rich ML, Stulac S, Murray MB, Binagwaho A. Impact of a health system strengthening intervention on maternal and child health outputs and outcomes in rural Rwanda 2005-2010. BMJ Glob Health. 2018; 3(2):e000674. PMID: 29662695; PMCID: PMC5898359.
    Citations: 9     Fields:    
  12. Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, Rich ML, Waning B, Furin J. Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2018 04 01; 22(4):407-412. PMID: 29562988.
    Citations: 13     Fields:    Translation:Humans
  13. Bonds MH, Ouenzar MA, Garchitorena A, Cordier LF, McCarty MG, Rich ML, Andriamihaja B, Haruna J, Farmer PE. Madagascar can build stronger health systems to fight plague and prevent the next epidemic. PLoS Negl Trop Dis. 2018 01; 12(1):e0006131. PMID: 29300731; PMCID: PMC5754047.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  14. Guglielmetti L, Varaine F, Huerga H, Bonnet M, Rich ML, Mitnick CD. Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance. Eur Respir J. 2017 07; 50(1). PMID: 28729476.
    Citations: 3     Fields:    Translation:HumansCells
  15. Parr JB, Rich ML, Keshavjee S, Franke MF, Mitnick CD, Bayona J, Becerra MC. Presumptive treatment of multidrug-resistant tuberculosis in household contacts. Int J Tuberc Lung Dis. 2016 Mar; 20(3):370-5. PMID: 27046719.
    Citations: 1     Fields:    Translation:HumansCells
  16. Farmer DB, Berman L, Ryan G, Habumugisha L, Basinga P, Nutt C, Kamali F, Ngizwenayo E, St Fleur J, Niyigena P, Ngabo F, Farmer PE, Rich ML. Motivations and Constraints to Family Planning: A Qualitative Study in Rwanda's Southern Kayonza District. Glob Health Sci Pract. 2015 May 13; 3(2):242-54. PMID: 26085021.
    Citations: 29     Fields:    Translation:Humans
  17. Franke MF, Becerra MC, Tierney DB, Rich ML, Bonilla C, Bayona J, McLaughlin MM, Mitnick CD. Counting pyrazinamide in regimens for multidrug-resistant tuberculosis. Ann Am Thorac Soc. 2015 May; 12(5):674-9. PMID: 25664920.
    Citations: 9     Fields:    Translation:HumansCells
  18. Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27; 5(9):a017863. PMID: 25918181; PMCID: PMC4561400.
    Citations: 85     Fields:    Translation:Humans
  19. Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death. Clin Infect Dis. 2014 Jul 01; 59(1):9-15. PMID: 24729493.
    Citations: 24     Fields:    Translation:HumansCells
  20. Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, Ngabo F, Wagner CM, Nutt CT, Nyatanyi T, Gatera M, Kayiteshonga Y, Mugeni C, Mugwaneza P, Shema J, Uwaliraye P, Gaju E, Muhimpundu MA, Dushime T, Senyana F, Mazarati JB, Gaju CM, Tuyisenge L, Mutabazi V, Kyamanywa P, Rusanganwa V, Nyemazi JP, Umutoni A, Kankindi I, Ntizimira C, Ruton H, Mugume N, Nkunda D, Ndenga E, Mubiligi JM, Kakoma JB, Karita E, Sekabaraga C, Rusingiza E, Rich ML, Mukherjee JS, Rhatigan J, Cancedda C, Bertrand-Farmer D, Bukhman G, Stulac SN, Tapela NM, van der Hoof Holstein C, Shulman LN, Habinshuti A, Bonds MH, Wilkes MS, Lu C, Smith-Fawzi MC, Swain JD, Murphy MP, Ricks A, Kerry VB, Bush BP, Siegler RW, Stern CS, Sliney A, Nuthulaganti T, Karangwa I, Pegurri E, Dahl O, Drobac PC. Rwanda 20 years on: investing in life. Lancet. 2014 Jul 26; 384(9940):371-5. PMID: 24703831; PMCID: PMC4151975.
    Citations: 71     Fields:    Translation:Humans
  21. Thomson DR, Rich ML, Kaigamba F, Socci AR, Hakizamungu M, Bagiruwigize E, Binagwaho A, Franke MF. Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study. AIDS Behav. 2014 Feb; 18(2):368-80. PMID: 23443977.
    Citations: 12     Fields:    Translation:Humans
  22. Binagwaho A, Nutt CT, Mutabazi V, Karema C, Nsanzimana S, Gasana M, Drobac PC, Rich ML, Uwaliraye P, Nyemazi JP, Murphy MR, Wagner CM, Makaka A, Ruton H, Mody GN, Zurovcik DR, Niconchuk JA, Mugeni C, Ngabo F, Ngirabega Jde D, Asiimwe A, Farmer PE. Shared learning in an interconnected world: innovations to advance global health equity. Global Health. 2013 Aug 30; 9:37. PMID: 24119388.
    Citations: 25     Fields:    Translation:Humans
  23. Kwan GF, Bukhman AK, Miller AC, Ngoga G, Mucumbitsi J, Bavuma C, Dusabeyezu S, Rich ML, Mutabazi F, Mutumbira C, Ngiruwera JP, Amoroso C, Ball E, Fraser HS, Hirschhorn LR, Farmer P, Rusingiza E, Bukhman G. A simplified echocardiographic strategy for heart failure diagnosis and management within an integrated noncommunicable disease clinic at district hospital level for sub-Saharan Africa. JACC Heart Fail. 2013 Jun; 1(3):230-6. PMID: 24621875.
    Citations: 29     Fields:    Translation:Humans
  24. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664. PMID: 23516529.
    Citations: 30     Fields:    Translation:Humans
  25. Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, Niyigena P, Walker KD, Epino H, Binagwaho A, Mukherjee J, Farmer PE, Rich ML. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis. 2013 May; 56(9):1319-26. PMID: 23249611.
    Citations: 64     Fields:    Translation:HumansCells
  26. Epino HM, Rich ML, Kaigamba F, Hakizamungu M, Socci AR, Bagiruwigize E, Franke MF. Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda. AIDS Care. 2012; 24(12):1576-83. PMID: 22428702.
    Citations: 17     Fields:    Translation:Humans
  27. Rich ML, Miller AC, Niyigena P, Franke MF, Niyonzima JB, Socci A, Drobac PC, Hakizamungu M, Mayfield A, Ruhayisha R, Epino H, Stulac S, Cancedda C, Karamaga A, Niyonzima S, Yarbrough C, Fleming J, Amoroso C, Mukherjee J, Murray M, Farmer P, Binagwaho A. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012 Mar 01; 59(3):e35-42. PMID: 22156912.
    Citations: 81     Fields:    Translation:HumansCells
  28. Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1315-22. PMID: 22283887.
    Citations: 10     Fields:    Translation:HumansCells
  29. Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011 Sep; 38(3):516-28. PMID: 21828024.
    Citations: 297     Fields:    Translation:HumansCellsPHPublic Health
  30. Franke MF, Stulac SN, Rugira IH, Rich ML, Bucyibaruta JB, Drobac PC, Iyamungu G, Bryant CM, Binagwaho A, Farmer PE, Mukherjee JS. High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda. Pediatr Infect Dis J. 2011 Jul; 30(7):614-6. PMID: 21206394.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  31. Kotagal M, Lee P, Habiyakare C, Dusabe R, Kanama P, Epino HM, Rich ML, Farmer PE. Improving quality in resource poor settings: observational study from rural Rwanda. BMJ. 2009 Oct 30; 339:b3488. PMID: 19880528.
    Citations: 19     Fields:    Translation:Humans
  32. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008 Oct 18; 372(9647):1403-9. PMID: 18723218.
    Citations: 63     Fields:    Translation:Humans
  33. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74. PMID: 18687637; PMCID: PMC2673722.
    Citations: 113     Fields:    Translation:HumansCells
  34. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007 Dec; 11(12):1314-20. PMID: 18034952.
    Citations: 47     Fields:    Translation:Humans
  35. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci. 2008; 1136:1-11. PMID: 17954675.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  36. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis. 2006 Sep; 12(9):1389-97. PMID: 17073088; PMCID: PMC3294733.
    Citations: 61     Fields:    Translation:HumansPHPublic Health
  37. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis. 2006 Apr; 10(4):402-8. PMID: 16602404.
    Citations: 46     Fields:    Translation:Humans
  38. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6. PMID: 16562709.
    Citations: 6     Fields:    Translation:Humans
  39. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005 Jun; 9(6):640-5. PMID: 15971391.
    Citations: 128     Fields:    Translation:Humans
  40. Saravia JC, Appleton SC, Rich ML, Sarria tM, Bayona J, Becerra MC. Retreatment management strategies when first-line tuberculosis therapy fails. Int J Tuberc Lung Dis. 2005 Apr; 9(4):421-9. PMID: 15830748.
    Citations: 10     Fields:    Translation:Humans
  41. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004 Feb 07; 363(9407):474-81. PMID: 14962530.
    Citations: 93     Fields:    Translation:Humans
  42. Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003 Jul; 7(7):637-44. PMID: 12870684.
    Citations: 11     Fields:    Translation:Humans
  43. Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Tuberculosis (Edinb). 2003; 83(1-3):59-65. PMID: 12758190.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rich's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (165)
Explore
_
Co-Authors (38)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.